Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I disagree completely. With a revenue base- last year- of 25 million in one of the the most rapidly growing sectors in existence right now, and a market cap of 1x revenues, the share price will rapidly rise like a rocket when uncertainty is removed. When the yield sign is removed and uplist occurs the share price will make the first leg up- soon. An expected increase in Q2 revs and earnings will cement the climb into the .50 area and higher. Additional catalysts include debt resolution and sales in national retail chains- hinted at in past PRs. If all is executed according to plan, laid out in past PRs, the potential here is vast. All IMO.
I have seen this before and it's a prearranged buy to some other person or company, possible a stakeholder.
The market cap is now approximately equal to 2019 potential revenues, and the upside is huge here. The float is still 346 million as we wait to hear why the CEO has unrestricted some shares this year. Based on the Harbinger research report on the POTN web site, it could be a stake holder or production partner. Patience will be rewarded IMO as we wait to hear about a national retail deal.
Absolutely agree. Since we are only 5 days out from 2 PRs claiming that POTN is fully reporting, I am thinking that the issue will be resolved very soon and Hagen must be confident about it.
Of course, the CEO hasn't released this info yet. IMO when the yield sign comes off, within days is my guess, POTN share price will fly back up 50% a day until uplist and earnings- the bigger drivers going forward. Hagen is working hard all day every day to make things happen. Takes time, time time...
POTN is a top retailer of CBD with a new salesforce in place, well positioned to profit from the huge growth in CBD sales discussed below. Looking forward to Q2 numbers.
https://www.fool.com/investing/2019/07/14/us-cbd-sales-to-grow-an-average-of-107-annually-th.aspx
The day the yield sign gets removed the share price will once again rise 50%. Next, we need to see a big increase in earnings IMO, and uncertainty will be much lower.
That's in part because 2019 revenue projection is $35 million conservatively. Q2 will be telling.
Get the FACTS here
https://www.potnetworkholding.com
Link to research report on POTN web site, enlighten yourself.
https://www.potnetworkholding.com/sites/all/themes/potn/images/potn-research-report.pdf
Conservative estimate of earnings growth this year is 40% which is $35 million according to the research report on POTN web site. Current market cap is less than 2X, ridiculous.
Up 15% today with yield still in place. When this is uplisted it will fly to .20 so fast that your head will spin. Then comes Q2 earnings- the next month is gonna be fun.
Looks like the CannTrust issue is no longer depressing the sector today, let's see some upward movement!
IMO the day the OTC site gets updated and the yield sign is removed POTN shareprice will start flying up 50% per day. Wouldn't it be nice if it was today.
Going to be a good day for the markets, cannabis,and and POTN. Back to 9s and 10s today $POTN
I think that a chunk of the recently unrestricted shares could be for a new stakeholder and/or production partner. I look forward to this new transparency mentioned in recent PRs.
So you are saying the numbers on the OTC web site are wrong about the float and restricted shares, and we should believe your numbers instead.
I thought Medipets would be one of the top sellers, we will see. IMO Claytrader is great for bringing in day trader volume.
We still have catalysts to look forward to such as uplist, revenues, short covering, more analyst coverage, and distribution deals with national chains to name a few. A slow steady rise with pullbacks is in line with expectations.
With a market cap of 2X LAST year's revenues in the fastest growing sector in the world, I consider .105 extremely undervalued for a top retail brand in the US. Nice to see that over 28 million shares were traded in one day at the very beginning of a run that achieved an increase of 40% in ONE day and top 5 breakout board. Much more is to come IMO, even if there is a pullback tomorrow.
I still think that the bigger news will be Q2 revenues and the plan for the recently unrestricted shares. Do they go to a big stakeholder or to resolve debt or to buy a CBD production company or other?
The news hasn't hit the wires yet, just wait.
OTCQB here we come. IMO we will soon see some exciting news about the unrestricted shares. Debt resolution or partner/ stakeholder are two possibilities that come to mind.
Great news! Things should happen quickly now, onward and upward.
Interesting article about the strategy of ACB to enter the US CBD market- they haven't announced a partner yet. IMO POTN is setting up to announce a retail partner that's a national chain of some kind or a big Canadian producer, my speculation only.
https://finance.yahoo.com/amphtml/news/why-aurora-cannabis-could-become-180000920.html
The float has not changed since 2018. There is no reason to think that a reverse split is in the cards.
I think we will have a sector reversal now, starting with CGC going back up (new CEO) and Cramer saying it's oversold. Canada was behind on licensing 600 new MJ stores and dispensaries and has now caught up, so revs should go back up this Q for Canadian stocks and improve the whole sector. I also think POTN will have much higher revs in Q2. They will have to in order to hit their projected 40% YOY increase.
The study was garbage, POTN has always posted analytical data about composition and purity of each product on the DiamondCBD web site. You might wait for Q2 earnings before you jump in though.
Somebody bought in this afternoon, sorry that you missed out.
POTN now has two years of audited earnings and has registered with the SEC for uplisting. Nobody knows when this will happen, though.
A highly suspicious study done in a non-peer reviewed journal that gives no info about the source or name or date or lot of the products tested - just a brand for a deliberate attack on one company- and most unbelievable- HAS NO DATA whatsoever, X's in a table, what a bad joke.
Here's where the big money will be made in MJ stocks: answer- not growers, but branded products (think DiamondCBD) and patented meds. Maybe this is why all of the big Canadian growers are in a rush to buy US brands?
https://www.marketwatch.com/story/heres-where-the-big-money-in-marijuana-stocks-will-be-made-2019-07-02?siteid=yhoof2&yptr=yahoo
I suspect that POTN is in a quiet period waiting for the SEC and uplist evaluations to be completed. It is wise to avoid PRs that could cause any problems. At my pharma company, we were told not to speak of our research to anybody outside of the company while waiting for FDA approval of IND status for a clinical trial.
In my opinion the key word is when, this company is running late on milestones as stated in PRs.
Cannabis is going to show HUGE growth in the next few years, starting with retail. You just need to know that POTN has a base of revs of $25 million, will be growing (conservatively) at 40% per year (analyst report on their website) and has been valued by research investment fund/lender at .45/share. POTN will uplist to OTCQB within a month, according to a past PR.
I too have heard from people that have met him or know him that Hagen is a smart, capable, hard working guy. I like his strategy of building up work force, introducing key, high quality new products and marketing. Based on PRs it 's working. Uplisting could come this week, and we have a base value going forward to 2020 of .45, as per DD by Illiad Research. Share price is very undervalued, and I think q2 revs will make that clear.
We haven't gotten to power hour yet.
Agree with your analysis, it is astounding how low the POTN market cap is in comparison to revenues. If and when POTN removes debt uncertainty and uplists, the sky is the limit with growing revenues.